Nova 301

This study is testing the safety and effectiveness of a new vaccine, mRNA-1403, to prevent acute gastroenteritis caused by norovirus.

Norovirus (commonly called ‘the vomiting bug’) is highly contagious, causing severe sickness and diarrhoea, particularly in winter months.

This phase 3 clinical trial is taking place across the UK and worldwide. It is sponsored by Moderna.

 

This study has ended and is currently not accepting new applicants.

Share this study

Research for the Future
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.